Morken CeCelia has filed 7 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 3436 shares of WELLS FARGO & COMPANY/MN ($WFC) on April 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 28, 2026 | WELLS FARGO & COMPANY/MN | $WFC | Morken CeCelia | Director | A | Common Stock Units | 3436 | $81.50 | 17,851.9647 | 3,148,900,000 | 23.83% | 0.00% |
| April 23, 2026 | Genpact LTD | $G | Morken CeCelia | Director | A | Common Shares | 6521 | $0.00 | 64,281.0000 | 177,197,356 | 11.29% | 0.00% |
| May 22, 2025 | Genpact LTD | $G | Morken CeCelia | Director | A | Common Shares | 4825 | $0.00 | 57,760.0000 | 180,436,900 | 9.11% | 0.00% |
| April 29, 2025 | WELLS FARGO & COMPANY/MN | $WFC | Morken CeCelia | Director | A | Common Stock Units | 3728 | $71.10 | 14,108.4723 | 3,288,900,000 | 35.91% | 0.00% |
| Dec. 7, 2023 | WELLS FARGO & COMPANY/MN | $WFC | Morken CeCelia | Director | G | Common Stock, $1 2/3 Par Value | 210 | $0.00 | 100.0000 | 0 | 67.74% | 0.00% |
| May 2, 2024 | Genpact LTD | $G | Morken CeCelia | Director | A | Common Shares | 6707 | $0.00 | 52,935.0000 | 185,141,843 | 14.51% | 0.00% |
| April 30, 2024 | WELLS FARGO & COMPANY/MN | $WFC | Morken CeCelia | Director | A | Common Stock Units | 4046 | $59.32 | 10,106.1884 | 3,598,900,000 | 66.76% | 0.00% |